Kin Ping Lee
Net worth: 774 091 $ as of 30/05/2026
Net worth: 774 091 $ as of 30/05/2026
Kin Ping Lee currently serves as Independent Director at Gracell Biotechnologies, Inc. since 2021 and as Chief Executive & Responsible Officer at Lotus Asset Management Ltd. Former roles include Chief Executive Officer-Asset Management at Sun Hung Kai & Co. Ltd., Chief Executive Officer at Sun Hung Kai Wealth Management Ltd., Chief Executive Officer at Bright Fund Management Ltd., Chief Executive Officer at Bright Fund Management LTD (Private Equity) in 2010, Chairman-Hong Kong Branch at The Alternative Investment Mgmt Association Ltd. (Singapore) from 2004 to 2012, Managing Director at FrontPoint Management (Hong Kong) Ltd., Executive Director-Investment Management Division at Goldman Sachs (Asia) LLC from 1997 to 2000, Independent Non-Executive Director at Goldstream Investment Ltd. from 2019 to 2025, and Chief Financial Officer at OrbusNeich Medical KK from 2012 to 2017.
Education includes an undergraduate degree from the University of Pennsylvania, conferred in 1991.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/12/2025 | 1,134,000 ( 0.44% ) | 774 091 $ | 30/05/2026 |
| Companies | Position | Start |
|---|---|---|
| GRACELL BIOTECHNOLOGIES INC. | Director/Board Member | 08/07/2021 |
Lotus Asset Management Ltd.
Lotus Asset Management Ltd. Investment ManagersFinance Provides investment advice | Chief Executive Officer | - |
| Companies | Position | End |
|---|---|---|
| GOLDSTREAM INVESTMENT LIMITED | Director/Board Member | 30/12/2025 |
Orbusneich Medical Co., Ltd.
Orbusneich Medical Co., Ltd. Medical DistributorsDistribution Services Manufactures and supplies medical and hospital equipment | Director of Finance/CFO | 28/02/2017 |
The Alternative Investment Mgmt Association Ltd. (Singapore) | Corporate Officer/Principal | 31/07/2012 |
Bright Fund Management Ltd.
Bright Fund Management Ltd. Investment ManagersFinance BFM is an active manager which invests through their alternative funds in a range of countries including North America, Europe, Asia ex-Japan, Japan, Middle East, Africa, Latin America, Canada and Australia. The firm employs complementary multi-factor and mean-reversion strategies, evaluating quarterly fundamental data and longer-term price actions and mean reversion between related companies, respectively. | President | 31/08/2010 |
Bright Fund Management LTD (Private Equity)
Bright Fund Management LTD (Private Equity) Investment ManagersFinance SHK Fund Management Ltd. (Private Equity) is an active manager which invests in listed and unlisted companies located in Greater China, Hong Kong, United States and the wider Asia-Pacific region. The firm provides financing in the form of equity loan notes, other equity or debt instruments for growth capital requirements. | Investment Committee Member | 31/08/2010 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 12 |
|---|---|
Goldstream Investment Ltd.
Goldstream Investment Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as an investment holding company, which engages in the provision of customer relationship management services | Commercial Services |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sun Hung Kai & Co. Ltd.
Sun Hung Kai & Co. Ltd. Finance/Rental/LeasingFinance Operates as an investment holding company which engages in the provision of financial services | Finance |
Sun Hung Kai Wealth Management Ltd.
Sun Hung Kai Wealth Management Ltd. Investment ManagersFinance Provides investment advice | Finance |
FrontPoint Management (Hong Kong) Ltd.
FrontPoint Management (Hong Kong) Ltd. Investment ManagersFinance FrontPoint-Hong Kong is an active, research-based manager which employs multiple strategies, including a Japan long/short strategy and an Asia Pacific (including Japan) strategy. They utilize a combination of fundamental analysis and bottom-up stock picking to make investments. The firm believes that the FrontPoint investment management platform and equity-oriented culture enables them to enhance their primary research capabilities and maintain a sustainable competitive edge across Asian markets. They collaborate with other FrontPoint managers to share information and focus on applying FrontPoint's portfolio management software development capabilities and independent risk management framework to manage investments. | Finance |
Goldman Sachs (Asia) LLC
Goldman Sachs (Asia) LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Bright Fund Management Ltd.
Bright Fund Management Ltd. Investment ManagersFinance BFM is an active manager which invests through their alternative funds in a range of countries including North America, Europe, Asia ex-Japan, Japan, Middle East, Africa, Latin America, Canada and Australia. The firm employs complementary multi-factor and mean-reversion strategies, evaluating quarterly fundamental data and longer-term price actions and mean reversion between related companies, respectively. | Finance |
Bright Fund Management LTD (Private Equity)
Bright Fund Management LTD (Private Equity) Investment ManagersFinance SHK Fund Management Ltd. (Private Equity) is an active manager which invests in listed and unlisted companies located in Greater China, Hong Kong, United States and the wider Asia-Pacific region. The firm provides financing in the form of equity loan notes, other equity or debt instruments for growth capital requirements. | Finance |
Orbusneich Medical Co., Ltd.
Orbusneich Medical Co., Ltd. Medical DistributorsDistribution Services Manufactures and supplies medical and hospital equipment | Distribution Services |
Lotus Asset Management Ltd.
Lotus Asset Management Ltd. Investment ManagersFinance Provides investment advice | Finance |
The Alternative Investment Mgmt Association Ltd. (Singapore) | |
Gracell Biotechnologies, Inc.
Gracell Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cell and gene therapy for the treatment of cancer and autoimmune diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions